A Review of Clinical and Pharmacogenetic Relationship Between Statin Use, Diabetes Mellitus, and Erectile Dysfunction
Main Article Content
Abstract
This study aimed to highlight the genetic and clinical associations among the statins, diabetes mellitus, and erectile dysfunction. Statins are regarded as the first-line therapy for dyslipidemia management and an essential medicine for controlling other cardiovascular risks. Several studies have found evidence of links between chronic statin use, diabetes mellitus, and reduction of sperm quality in humans; however, the mechanism of action has not been thoroughly investigated. Clinical studies showed evidence for the impact of statins on the diabetes mellitus, which in turn worsened the erectile dysfunction. This chain is discussed in the present literature study. There are 44 genes associated with statin pharmacodynamics, which are primarily classified as cholesterogenic and lipogenic genes. Statins have a negative effect on the genes that produce testosterone. These genes suppress the production and release of the testosterone hormone, which is considered the leading cause of erectile dysfunction. There is a lack of evidence on the genetic role of erectile dysfunction in statin use, which necessitates additional research on this topic. Furthermore, the effect of comorbidities such as diabetes mellitus should be studied among different ethnicities as an influencing factor to better understand the screening and prevention of patients with genetic risk factors and to support the investigation of future genetic therapies. This study concluded the significance of the genetic influence of statins and diabetes melilites on the erectile dysfunction.
Downloads
Article Details
References
Goodman CA, Pol D, Zacharewicz E, Lee-Young RS, Snow RJ, Russell AP, McConnell, GK. Statin-induced increases in atrophy gene expression occur independently of changes in PGC1α protein and mitochondrial content. PloS ONE. 2015; 28: 10(5). doi: 10.1371/journal.pone.0128398.
Zodda D, Giammona R, Schifilliti S. Treatment Strategy for Dyslipidemia in Cardiovascular Disease Prevention: Focus on Old and New Drugs. Pharmacy. 2018; 6(1): 10. doi:10.3390/pharmacy6010010.
El-Ganainy SO, El-Mallah A, Abdallah D, Khattab MM, Mohy El-Din MM, El-Khatib AS. Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model. Toxicology. 2016;3 59-360: 29-38. doi: 10.1016/j.tox.2016.06.015.
Keber R, Rozman D, Horvat S. Sterols in spermatogenesis and sperm maturation. J Lipid Res. 2013; 54(1): 20-33. doi: 10.1194/jlr.R032326
Puga Molina LC, Luque GM, Balestrini PA, Marín-Briggiler CI, Romarowski A, Buffone MG. Molecular Basis of Human Sperm Capacitation. Front Cell Dev Biol. 2018; 6:72. doi: 10.3389/fcell.2018.00072.
Jin SK, Yang WX. Factors and pathways involved in capacitation: how are they regulated? Oncotarget. 2017; 8(2): 3600-3627. doi: 10.18632/oncotarget.12274.
Saez F, Drevet JR. Dietary Cholesterol and Lipid Overload: Impact on Male Fertility. Oxid Med Cell Longev. 2019;2019:4521786. doi:10.1155/2019/4521786
Chen L, Shi GR, Huang DD, Li Y, Ma CC, Shi M, Su BX, Shi GJ. Male sexual dysfunction: A review of literature on its pathological mechanisms, potential risk factors, and herbal drug intervention. Biomed Pharmacother. 2019; 112: 108585. doi: 10.1016/j.biopha.2019.01.046.
Nordin RB, Soni T, Kaur A, Loh KP, Miranda S. Prevalence and predictors of erectile dysfunction in adult male outpatient clinic attendees in Johor, Malaysia. Singapore Med J. 2019; 60(1): 40-47. doi: 10.11622/smedj.2018049.
Allen MS, Walter EE. Health-Related Lifestyle Factors and Sexual Dysfunction: A Meta-Analysis of Population-Based Research. J Sex Med. 2018; 15(4): 458-475. doi: 10.1016/j.jsxm.2018.02.008.
Salvio G, Martino M, Giancola G, Arnaldi G, Balercia G. Hypothalamic-Pituitary Diseases and Erectile Dysfunction. J Clin Med. 2021; 10(12): 2551. doi: 10.3390/jcm10122551.
Miller TA. Diagnostic evaluation of erectile dysfunction. Am Fam Physician. 2000 Jan 1;61(1):95-104, 109-10.
Galicia-Garcia U, Jebari S, Larrea-Sebal A, Uribe KB, Siddiqi H, Ostolaza H, Benito-Vicente A, Martín C. Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights. Int J Mol Sci. 2020; 21(13): 4725. doi: 10.3390/ijms21134725.
Tangelloju S, Little BB, Esterhay RJ, Brock G, LaJoie S. Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients ≥65 years. Diabetes Metab Res Rev. 2020; 36(6): e3310. doi: 10.1002/dmrr.3310.
Carmena R, Betteridge DJ. Diabetogenic Action of Statins: Mechanisms. Curr Atheroscler Rep. 2019; 21(6): 23. doi: 10.1007/s11883-019-0780-z.
Margerie D, Lefebvre P, Raverdy V, Schwahn U, Ruetten H, et al. Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients. BMC Med Genomics. 2019; 12(1): 80. doi: 10.1186/s12920-019-0536-1.
Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, Voros S, Giugliano RP, Davey Smith G, Fazio S, Sabatine MS. Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. N Engl J Med. 2016; 375(22): 2144-2153. doi: 10.1056/NEJMoa1604304.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009; 32 Suppl 1(Suppl 1): S62-7. doi: 10.2337/dc09-S062.
Sèdes L, Thirouard L, Maqdasy S, Garcia M, Caira F, Lobaccaro JA, Beaudoin C, Volle DH. Cholesterol: A Gatekeeper of Male Fertility? Front Endocrinol (Lausanne). 2018; 9: 369. doi: 10.3389/fendo.2018.00369.
National Center of Biotechnology (2022a). CYP17A1 cytochrome P450 family 17 subfamilies A member 1 [ Homo sapiens (human)]. NIH, Available from the source https://www.ncbi.nlm.nih.gov/gene/1586.
National Center of Biotechnology (2022b). SULT2A1 sulfotransferase family 2A member 1 [ Homo sapiens (human)]. NIH, Available from the source https://www.ncbi.nlm.nih.gov/gene/6822.
Pott J, Bae YJ, Horn K, Teren A, Kühnapfel A, Kirsten H, Ceglarek U, Loeffler M, Thiery J, Kratzsch J, Scholz M. Genetic Association Study of Eight Steroid Hormones and Implications for Sexual Dimorphism of Coronary Artery Disease. J Clin Endocrinol Metab. 2019; 104(11): 5008-5023. doi: 10.1210/jc.2019-00757.
Banihani SA. Effect of statin on semen quality characteristics. Andrologia. 2020; 52(6): e13592. doi: 10.1111/and.13592.
Klinefelter GR., Laskey JW, Amann RP. Statin drugs markedly inhibit testosterone production by rat Leydig cells in vitro: Implications for men. Reprod Toxicol. 2014; 45: 52-58. https://doi.org/10.1016/j.reprotox.2013.12.010.
Knuth UA, Hönigl W, Bals-Pratsch M, Schleicher G, Nieschlag E. Treatment of severe oligospermia with human chorionic gonadotropin/human menopausal gonadotropin: a placebo-controlled, double blind trial. J Clin Endocrinol Metab. 1987; 65(6): 1081-7. doi: 10.1210/jcem-65-6-1081.
Tatem AJ, Beilan J, Kovac JR, Lipshultz LI. Management of Anabolic Steroid-Induced Infertility: Novel Strategies for Fertility Maintenance and Recovery. World J Mens Health. 2020; 38(2): 141-150. doi: 10.5534/wjmh.190002.
Li YX, Guo X, Gulappa T, Menon B, Menon KMJ. SREBP Plays a Regulatory Role in LH/hCG Receptor mRNA Expression in Human Granulosa-Lutein Cells. J Clin Endocrinol Metab. 2019; 104(10): 4783-4792. doi: 10.1210/jc.2019-00913.
Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes. 2014; 7: 241-253. doi: 10.2147/DMSO.S43731.
Stamerra CA, Di Giosia P, Ferri C, Giorgini P, Reiner Z, Johnston TP, Sahebkar A. Statin therapy and sex hormones. Eur J Pharmacol. 2021; 890: 173745. doi: 10.1016/j.ejphar.2020.173745.
Omolaoye TS, Cyril AC, Radhakrishnan R, Rawat SS, Karuvantevida N, du Plessis SS. The Effect of Statins on Male Reproductive Parameters: A Mechanism Involving Dysregulation of Gonadal Hormone Receptors and TRPV1. Int J Mol Sci. 2023; 24(11): 9221. doi: 10.3390/ijms24119221.
Keihani S, Martin C, Craig JR, Zhang C, Presson AP, Myers JB, Aston KI, Emery BR, Carrell DT, Hotaling JM. Semen parameters are unaffected by statin use in men evaluated for infertility. Andrologia. 2018; 50(5): e12995. doi: 10.1111/and.12995.
La Vignera S, Condorelli RA, Vicari E, Calogero AE. Statins and erectile dysfunction: a critical summary of current evidence. J Androl. 2012; 33(4): 552-8. doi: 10.2164/jandrol.111.015230.
Cai X, Tian Y, Wu T, Cao CX, Bu SY, Wang KJ. The role of statins in erectile dysfunction: a systematic review and meta-analysis. Asian J Androl. 2014; 16(3): 461-466. doi: 10.4103/1008-682X.123678.
Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Family Practice. 2002; 19(1): 95–98. https://doi.org/10.1093/fampra/19.1.95.
Zhaobao L. Statin-induced erectile dysfunction. Adverse Drug React J. 2010; 12(2):105-4.
Stanworth RD, Kapoor D, Channer KS, Jones TH. Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes. Diabetes Care. 2009; 32(4): 541-6. doi: 10.2337/dc08-1183.
Kostis JB, Dobrzynski JM. Statins and Erectile Dysfunction. World J Mens Health. 2019; 37(1): 1-3. doi: 10.5534/wjmh.180015.
Baspınar O, Bayram F, Korkmaz S, Aksu M, Kocer D, Dizdar OS, Simsek Y, Toth PP. The effects of statin treatment on adrenal and sexual function and nitric oxide levels in hypercholesterolemic male patients treated with a statin. J Clin Lipidol. 2016;10(6):1452-1461. doi: 10.1016/j.jacl.2016.09.004.
Nurkalem Z, Yildirimtürk Ö, Özcan KS, Kul Ş, Çanga Y, Satılmış S, Bozbeyoğlu E, Kaya C. The effect of rosuvastatin and atorvastatin on erectile dysfunction in hypercholesterolaemic patients. Kardiol Pol. 2014; 72(3): 275-9. doi: 10.5603/KP.a2013.0287.
Solomon H, Samarasinghe YP, Feher MD, Man J, Rivas-Toro H, Lumb PJ, Wierzbicki AS, Jackson G. Erectile dysfunction and statin treatment in high cardiovascular risk patients. Int J Clin Pract. 2006; 60(2): 141-5. doi: 10.1111/j.1742-1241.
Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol. 2017; 13(12): 710-730. doi: 10.1038/nrendo.2017.91.
Wang B, Tontonoz P. Liver X receptors in lipid signalling and membrane homeostasis. Nat Rev Endocrinol. 2018; 14(8): 452-463. doi: 10.1038/s41574-018-0037-x.
Chugh RM, Park HS, Esfandyari S, Elsharoud A, Ulin M, Al-Hendy A. Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2. Int J Mol Sci. 2021; 22(17): 9184. doi: 10.3390/ijms22179184.
SR, Fish-Trotter H, Williams RW, Childress RD, Raghow R. Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge. PLoS One. 2017; 12(8): e0181308. doi: 10.1371/journal.pone.0181308.
Kee PS, Chin PKL, Kennedy MA, Maggo SDS. Pharmacogenetics of Statin-Induced Myotoxicity. Front Genet. 2020; 11: 575678. doi: 10.3389/fgene.2020.575678.
Schweizer MT, Yu EY. Targeting intratumoral androgens: statins and beyond. Ther Adv Med Oncol. 2016 Sep;8(5):388-95. doi: 10.1177/1758834016647962.
Poniah P, Mohamed Z, Apalasamy YD, Mohd Zain S, Kuppusamy S, Razack AH. Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. Int J Clin Exp Med. 2015; 8(10): 19232-40.
Donnelly LA, Doney AS, Tavendale R, Lang CC, Pearson ER, et al. Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther. 2011; 89(2): 210-6. doi: 10.1038/clpt.2010.255.
Park JH, Lee J, Kim CH, Lee S. The polymorphism (-600 C>A) of CpG methylation site at the promoter region of CYP17A1 and its association of male infertility and testosterone levels. Gene. 2014; 534(1): 107-12. doi: 10.1016/j.gene.2013.09.088.
Yang SJ, Lee ST, Kim WJ, Park SE, Park SW, Kim JW, Park CY. Genetic variation in CYP17A1 is associated with arterial stiffness in diabetic subjects. Exp Diabetes Res. 2012; 2012: 827172. doi: 10.1155/2012/827172.
Okin D, Medzhitov R. The Effect of Sustained Inflammation on Hepatic Mevalonate Pathway Results in Hyperglycemia. Cell. 2016; 165(2): 343-56. doi: 10.1016/j.cell.2016.02.023.
Ortega I, Cress AB, Wong DH, Villanueva JA, Sokalska A, Moeller BC, Stanley SD, Duleba AJ. Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells. Biol Reprod. 2012; 86(1): 1-9. doi: 10.1095/biolreprod.111.094714
Sathyapalan T, Smith KA, Coady AM, Kilpatrick ES, Atkin SL. Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study. Ann Clin Biochem. 2012; 49(Pt 1): 80-5. doi: 10.1258/acb.2011.011071.
Lee JA, Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Transl Androl Urol. 2018; 7(Suppl 3): S348-S352. doi: 10.21037/tau.2018.04.11.